To the Editor In their review article,1 Drs Kok and Reynolds discussed the clinical challenge of treating late-life depression. They provided an exhaustive analysis of pharmacological treatments, including dosing, intensity, harmful effects, target populations, and clinical significance and offered useful clinical information and directions for future research. However, their analysis of other treatments lacked depth and they missed an important opportunity to provide readers an understanding of the full range of proven approaches for addressing late-life depression.
Gitlin LN, Aravena JM. Nonpharmacologic Treatments for Depression in Older Adults. JAMA. 2017;318(13):1283–1284. doi:10.1001/jama.2017.12020
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.